Anti-psoriasis mechanism studies have indicated that compound 5c reduced the secretion of IL-1β, IL-6, IL-8 and IL-24 in an IMQ-stimulated model and could also attenuate the activation of IMQ-induced MAPKs, including JNK1/2 and ERK1/2. Here, MAPK3 is linked to psoriasis.